mecamylamine has been researched along with Apoplexy in 2 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Oliveira, RC | 1 |
de Oliveira, R | 1 |
Biagioni, AF | 1 |
Falconi-Sobrinho, LL | 1 |
Coimbra, NC | 1 |
Ofek, K | 1 |
Schoknecht, K | 1 |
Melamed-Book, N | 1 |
Heinemann, U | 1 |
Friedman, A | 1 |
Soreq, H | 1 |
2 other studies available for mecamylamine and Apoplexy
Article | Year |
---|---|
Dorsal raphe nucleus acetylcholine-mediated neurotransmission modulates post-ictal antinociception: The role of muscarinic and nicotinic cholinergic receptors.
Topics: Acetylcholine; Analgesics; Animals; Atropine; Dorsal Raphe Nucleus; Epilepsy, Tonic-Clonic; GABAergi | 2016 |
Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling.
Topics: Acetylcholinesterase; Animals; Arterioles; Atropine; Calcium; Cells, Cultured; Cerebral Cortex; Dise | 2012 |